Cholesterol emboli syndrome natural history, complications and prognosis

Jump to navigation Jump to search

Cholesterol emboli syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cholesterol emboli syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholesterol emboli syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholesterol emboli syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholesterol emboli syndrome natural history, complications and prognosis

CDC on Cholesterol emboli syndrome natural history, complications and prognosis

Cholesterol emboli syndrome natural history, complications and prognosis in the news

Blogs on Cholesterol emboli syndrome natural history, complications and prognosis

Directions to Hospitals Treating Cholesterol emboli syndrome

Risk calculators and risk factors for Cholesterol emboli syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

Overview

Common complications of Cholesterol emboli syndrome include atheroembolic renal disease, acute kidney injury, chronic kidney disease, myocardial infarction, cerebrovascular accident bowel ischemia, liver failure, end organ damage and death. Prognosis is generally poor, and the incidence of mortality among patients with Cholesterol emboli syndrome is approximately 63-80 %.

Natural History, Complications and Prognosis

References

  1. 1.0 1.1 Agrawal, Akanksha; Ziccardi, Mary Rodriguez; Witzke, Christian; Palacios, Igor; Rangaswami, Janani (2018). "Cholesterol embolization syndrome: An under-recognized entity in cardiovascular interventions". Journal of Interventional Cardiology. 31 (3): 407–415. doi:10.1111/joic.12483. ISSN 0896-4327.
  2. Ozkok, Abdullah (2019). "

    Cholesterol-embolization syndrome: current perspectives

    ". Vascular Health and Risk Management. Volume 15: 209–220. doi:10.2147/VHRM.S175150. ISSN 1178-2048.
  3. Fine, Michael J.; Kapoor, Wishwa; Falanga, Vincent (2016). "Cholesterol Crystal Embolization: A Review of 221 Cases in the English Literature". Angiology. 38 (10): 769–784. doi:10.1177/000331978703801007. ISSN 0003-3197.

Template:WikiDoc Sources